HIV Prevention ProgramPrEPSchoolNCT07053527
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU
A study testing PrEP Awareness and Uptake Educational Program in people with HIV Prevention Program, run by Morehouse School of Medicine at 1 site in United States.
Trial summary
This study involves a peer-educator/navigation model targeting gaps in PrEP awareness, uptake, and access in priority populations. Read more about this study
- Who is it for?
- Ages 18 to 26 yearsHealthy volunteers can take part
- Conditions the study is for
- HIV Prevention Program
- What is being tested?
- PrEP Awareness and Uptake Educational Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 123 participants
- Where
- 1 siteUnited States
- Study dates
- 23 Sep 2025to 31 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 26 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- 18-26 years old
- not currently on PrEP
- English speaking
- HIV negative
- 5) Enrolled in the following universities: Spellman College, Morehouse College, Clark Atlanta University, Morehouse school of medicine
Who cannot join
- Age < 18 years old
- Non-English speaking
- HIV positive
- Not currently enrolled any of the four colleges/universities
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Morehouse School of Medicine
Atlanta, Georgia, 30310
About this study
This study involves a peer-educator/navigation model targeting gaps in PrEP awareness, uptake, and access in priority populations.
Read the detailed description
The study focuses on increasing awareness and uptake of Pre-Exposure Prophylaxis (PrEP) for HIV prevention among African American college students at a consortium of historically Black colleges and universities in Atlanta, GA.
- Conditions
- HIV Prevention Program
- Being tested
- PrEP Awareness and Uptake Educational Program
- Keywords
- Preexposure Prophylaxis, PrEP Awareness, PrEP Access, PrEP Uptake, HIV Prevention, Peer education, HBCU
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PrEP Awareness and Uptake Educational ProgramBehavioural
This intervention targets African American college students aged 18-26 using a tailored, community participatory approach. It is delivered by trained peer educators and focuses on increasing PrEP awareness, access, and uptake through interactive, behaviorally focused sessions. Developed with input from focus groups to ensure relevance, the program includes a 6-month follow-up to assess sustained impact, distinguishing it from general PrEP education efforts.
| Study group | Role | What they receive |
|---|---|---|
| Educational Intervention Arm: African American College Students Receiving PrEP Awareness Sessions | Experimental | Develop a peer-educator/navigation intervention to help decrease stigma and discrimination and foster knowledge around PrEP use, in the prevention of HIV Receives: Behavioral: PrEP Awareness and Uptake Educational Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Pre-Exposure Prophylaxis for HIV at an HBCU Consortium
The Primary endpoint will be increased awareness, acceptability and access of PrEP by measuring pre-post surveys after peer-educator/navigator educational intervention.
Measured: 12 months
Secondary outcomes (1)
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Pre-Exposure Prophylaxis for HIV at an HBCU Consortium
The secondary endpoint will be measuring clinic data assessing the proportion of college students who initiated PrEP post educational intervention over a 12 months period.
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2025
- Study start23 Sep 2025
- Primary completionJul 2026 (estimated)
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for HIV Prevention ProgramStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 123 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Morehouse School of Medicine
- Sponsor type
- University, hospital or other
- Collaborators
- Gilead Sciences
- Responsible party
- Principal investigator, Kara Garretson, MPH, Morehouse School of Medicine
- Investigators
- Kara Garretson, Principal investigator, Morehouse School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07053527
- Sponsor's protocol ID
- 2264597
- Acronym
- PrEPSchool
- Status last verified
- Mar 2026
- First submitted
- 2 Jun 2025
- Last updated
- 9 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Weber S, Lazar L, McCord A, Romero C, Tan J. Online Navigation for Pre-Exposure Prophylaxis via PleasePrEPMe Chat for HIV Prevention: Protocol for a Development and Use Study. JMIR Res Protoc. 2020 Sep 22;9(9):e20187. doi: 10.2196/20187.
PubMed 32960183Truong HM, Pipkin S, O'Keefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S. Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco. J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):606-9. doi: 10.1097/QAI.0000000000000681.
PubMed 25967271Pichon LC, Teti M, McGoy S, Murry VM, Juarez PD. Engaging Black men who have sex with men (MSM) in the South in identifying strategies to increase PrEP uptake. BMC Health Serv Res. 2022 Dec 7;22(1):1491. doi: 10.1186/s12913-022-08914-2.
PubMed 36476363Okeke NL, McLaurin T, Gilliam-Phillips R, Wagner DH, Barnwell VJ, Johnson YM, James O, Webb PB, Parker SD, Hill B, McKellar MS, Mitchell JT. Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey. BMC Public Health. 2021 May 19;21(1):943. doi: 10.1186/s12889-021-10996-2.
PubMed 34006245
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU
- ClinicalTrials.gov ID
- NCT07053527
- Acronym / sponsor ID
- PrEPSchool / 2264597
- Conditions
- HIV Prevention Program
- Keywords
- Preexposure Prophylaxis, PrEP Awareness, PrEP Access, PrEP Uptake, HIV Prevention, Peer education, HBCU
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 123 participants (estimated)
- Lead sponsor
- Morehouse School of MedicineUniversity, hospital or other
- Collaborators
- Gilead Sciences
- Study start
- 23 Sep 2025 (actual)
- Primary completion
- Jul 2026 (estimated)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 8 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study involves a peer-educator/navigation model targeting gaps in PrEP awareness, uptake, and access in priority populations.
Detailed description
The study focuses on increasing awareness and uptake of Pre-Exposure Prophylaxis (PrEP) for HIV prevention among African American college students at a consortium of historically Black colleges and universities in Atlanta, GA.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Educational Intervention Arm: African American College Students Receiving PrEP Awareness Sessions | Experimental | Behavioral: PrEP Awareness and Uptake Educational ProgramDevelop a peer-educator/navigation intervention to help decrease stigma and discrimination and foster knowledge around PrEP use, in the prevention of HIV |
Who may qualify
- Ages
- 18 to 26 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- 18-26 years old
- not currently on PrEP
- English speaking
- HIV negative
- 5) Enrolled in the following universities: Spellman College, Morehouse College, Clark Atlanta University, Morehouse school of medicine
Key exclusion criteria (4 listed)
- Age < 18 years old
- Non-English speaking
- HIV positive
- Not currently enrolled any of the four colleges/universities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PrEP Awareness and Uptake Educational ProgramThis intervention targets African American college students aged 18-26 using a tailored, community participatory approach. It is delivered by trained peer educators and focuses on increasing PrEP awareness, access, and uptake through interactive, behaviorally focused sessions. Developed with input from focus groups to ensure relevance, the program includes a 6-month follow-up to assess sustained impact, distinguishing it from general PrEP education efforts. | Behavioural | Educational Intervention Arm: African American College Students Receiving PrEP Awareness Sessions |
Primary outcome
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Pre-Exposure Prophylaxis for HIV at an HBCU Consortium
Time frame: 12 months
The Primary endpoint will be increased awareness, acceptability and access of PrEP by measuring pre-post surveys after peer-educator/navigator educational intervention.
1 secondary outcome
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Pre-Exposure Prophylaxis for HIV at an HBCU Consortium
Time frame: 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2026.
- Background: PubMed 32960183Weber S, Lazar L, McCord A, Romero C, Tan J. Online Navigation for Pre-Exposure Prophylaxis via PleasePrEPMe Chat for HIV Prevention: Protocol for a Development and Use Study. JMIR Res Protoc. 2020 Sep 22;9(9):e20187. doi: 10.2196/20187.
- Background: PubMed 25967271Truong HM, Pipkin S, O'Keefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S. Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco. J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):606-9. doi: 10.1097/QAI.0000000000000681.
- Background: PubMed 36476363Pichon LC, Teti M, McGoy S, Murry VM, Juarez PD. Engaging Black men who have sex with men (MSM) in the South in identifying strategies to increase PrEP uptake. BMC Health Serv Res. 2022 Dec 7;22(1):1491. doi: 10.1186/s12913-022-08914-2.
- Background: PubMed 34006245Okeke NL, McLaurin T, Gilliam-Phillips R, Wagner DH, Barnwell VJ, Johnson YM, James O, Webb PB, Parker SD, Hill B, McKellar MS, Mitchell JT. Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey. BMC Public Health. 2021 May 19;21(1):943. doi: 10.1186/s12889-021-10996-2.
Related trials for HIV Prevention Program
Not yet recruiting
Evaluating the Healthy Families PrEP Program for Women at Risk for HIV
HIV, Pregnancy
RecruitingPhase 4
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
HIV Prevention, HIV Pre-exposure Prophylaxis
Active, not recruiting
Integrated Online-to-offline (O2O) Model of Care for HIV Prevention and Treatment Among Men Who Have Sex With Men
HIV Prevention Program
Active, not recruiting
Pre-exposure Prophylaxis (PrEP) for Health
Substance Dependence, HIV (Human Immunodeficiency Virus)
Active, not recruiting
Integrated Online-to-offline (O2O) Model of Care for HIV Prevention and Treatment Among Transgender Women (CINTAI)
HIV Prevention Program
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kara Garretson principal investigator
Morehouse School of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing PrEP Awareness and Uptake Educational Program in people with HIV Prevention Program, run by Morehouse School of Medicine at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Pre-Exposure Prophylaxis for HIV at an HBCU Consortium (time frame: 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07053527, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.